FDAMA In Action? ODE Shows Progress On IDE Supplements, Five-Day Notice
This article was originally published in The Gray Sheet
Executive Summary
The Center for Devices and Radiological Health is addressing industry concerns over FDA's handling of increasing numbers of investigational device exemption supplements and use of the agency's five-day notice program for clinical trial changes